Combining the long tradition of vaccine development of Ceva Phylaxia in Hungary and the cutting edge technology of Biomune in USA the company is committed to develop innovative vaccines that can meet the current needs to ensure that health of the animals...

  • COGLAVAX®  (Clostridiosis): It is a vaccine that contains 8 different clostridial antigens in one single dose. Clostridial pathogens are ubiquitious and cattle are at risk to be hit by these diseases during most of their lives
  • COXEVAC® (Coxiellosis or Q fever): It is a vaccine to protect against Q fever. This disease causes significant reproductive losses in both cattle and small ruminants. Moreover is a zoonosis therefore humans can be infected and suffer from the disease too. It has the advantage of being a so-called "phase 1" vaccine which, when used for prevention, not only improves clinical impact, but also considerably reduces or even eliminates excretion in vaccinated animals, thereby limiting contamination of the external environment.
  • MYCOMUNE®  (Mycoplasma bovis)

From one country to another, product lines are adapted to local demand and regulatory requirements. For further information, please take a look at the Ceva Santé Animale site for your country. Warning: the information provided on the products depends on national registrations. Access to technical information is restricted to authorised persons.

Back to top